Pankaj Gupta

Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction

G. McCann, J. Khan, Anvesha Singh, 2020, The International Journal of Cardiovascular Imaging.

Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction

Zhuyin Li, G. McCann, J. Khan, 2020, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

G. McCann, J. Khan, Anvesha Singh, 2020, ESC heart failure.

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction

G. McCann, J. Khan, Anvesha Singh, 2019, The International Journal of Cardiovascular Imaging.

Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction

J. Khan, Anvesha Singh, P. Kanagala, 2020, The International Journal of Cardiovascular Imaging.

Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use

P. Skipp, B. Keevil, W. Heywood, 2022, Clinical chemistry and laboratory medicine.

Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach

J. Khan, Anvesha Singh, P. Kanagala, 2020, PloS one.

Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.

P. Patel, J. Khan, Anvesha Singh, 2019, JACC. Cardiovascular imaging.